TargetMol

AC-42

Product Code:
 
TAR-T26541
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26541-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26541-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26541-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AC-42 is an allosteric agonist of M1 muscarinic receptor.
CAS:
244291-63-2
Formula:
C20H31NO
Molecular Weight:
301.474
Purity:
0.98
SMILES:
CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1

References

1. Stoehlmacher J, Goekkurt E, Hoeffken G, Zinsky R, Lynch F, Buettner H, Scheil-Bertram S, Schirren J, Ehninger G, Fisseler-Eckhoff A. Thymidylate synthase polymorphisms and immunohistochemistry in non-small cell lung cancer. J Clin Oncol. 2009 May 20;27(15_suppl):11101. PubMed PMID: 27963465. 2. Danielsson E, Zindovic I, Bjursten H, Ingemansson R, Nozohoor S. Generalized ischaemia in type A aortic dissections predicts early surgical outcomes only. Interact Cardiovasc Thorac Surg. 2015 Nov;21(5):583-9. doi: 10.1093/icvts/ivv198. PubMed PMID: 26197811. 3. Arslan B, Bozkurt IH, Yonguc T, Vardar E, Degirmenci T, Kozacioglu Z, Gunlusoy B, Minareci S. Clinical features and outcomes of nontransitional cell carcinomas of the urinary bladder: Analysis of 125 cases. Urol Ann. 2015 Apr-Jun;7(2):177-82. doi: 10.4103/0974-7796.150533. PubMed PMID: 25838209; PubMed Central PMCID: PMC4374255. 4. Nickols HH, Conn PJ. Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis. 2014 Jan;61:55-71. doi: 10.1016/j.nbd.2013.09.013. Review. PubMed PMID: 24076101; PubMed Central PMCID: PMC3875303.